Skip to main content

Table 1 Patient characteristics

From: Biomarkers for antimicrobial stewardship: a reappraisal in COVID-19 times?

 

Secondary infection (n = 33)

No secondary infection (n = 33)

p value

Sex

 Male, n (%)

26 (79%)

23 (70%)

0.57

 Female, n (%)

7 (21%)

10 (30%)

Age, years

67 [60–73]

65 [56–70]

0.17

BMI, kg/m2

27.6 [25.4–31.1]

27.7 [24.3–30.7]

0.40

APACHE II

15 [13–19]

15 [10–19]

0.77

Days between COVID-19 symptoms and hospital admission

7 [4–10]

7 [5–11]

0.72

Days between COVID-19 symptoms and ICU admission

10 [7–13]

10 [6–14]

0.96

Day of secondary infection (relative to hospital admission)

16 [13–22]

NA

 

Day of secondary infection (relative to ICU admission)

14 [9–21]

NA

 

Medical history, n (%)

 Cardiovascular insufficiency

9 (27%)

9 (27%)

1.00

 Hypertension

17 (52%)

16 (48%)

1.00

 Respiratory insufficiency

2 (6%)

3 (9%)

1.00

 Renal insufficiency

0 (0%)

1 (3%)

1.00

 Metastatic neoplasm

2 (6%)

3 (9%)

1.00

 Immunological insufficiency

0 (0%)

1 (3%)

1.00

 COPD

3 (9%)

3 (9%)

1.00

 Diabetes

11 (33%)

4 (12%)

0.08

 Hematologic malignancy

0 (0%)

1 (3%)

1.00

  1. Continuous data are presented as median [interquartile range]. p values were calculated using Mann-Whitney U tests (continuous data) and Fisher exact tests (categorical data)
  2. NA not applicable